TCTR20160122002
Not yet recruiting
未知
A randomized controlled trial of a regular diet as the first meal compared with traditional feeding in patients undergoing cesarean section
amphun Hospital0 sites438 target enrollmentJanuary 22, 2016
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- diet after cesarean section
- Sponsor
- amphun Hospital
- Enrollment
- 438
- Status
- Not yet recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Pregnant women who were scheduled to undergo
- •section for various indications were enrolled in the
- •study after informed consent might have been
Exclusion Criteria
- •The exclusion criteria included women with
- •severe uncontrolled medical conditions, e.g. diabetes mellitus, severe
- •pre\-eclampsia/eclampsia where patient needed intensive
- •care in labour and post\-partum, previous
- •bowel injury and previous surgery that involved
- •extensive lysis of adhesions of bowel.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaHypercholesterolaemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2017-001903-60-DKSanofi-aventis recherche & développement500
Active, not recruiting
Phase 1
An Efficacy and Safety Study of Alirocumab in Children and Adolescents with Heterozygous Familial HypercholesterolemiaHypercholesterolaemiaMedDRA version: 20.0Level: PTClassification code 10020603Term: HypercholesterolaemiaSystem Organ Class: 10027433 - Metabolism and nutrition disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2017-001903-60-HUSanofi-aventis recherche & développement500
Active, not recruiting
Phase 1
Study to Evaluate the Safety and Efficacy of Crinecerfont in Pediatric Patients With Classic Congenital Adrenal HyperplasiaClassic Congenital Adrenal Hyperplasia (CAH)MedDRA version: 20.0Level: LLTClassification code 10010323Term: Congenital adrenal hyperplasiaSystem Organ Class: 100000004850Therapeutic area: Diseases [C] - Hormonal diseases [C19]EUCTR2020-004381-19-ESeurocrine Biosciences, Inc.81
Active, not recruiting
Phase 1
This is a Study to Evaluate the Safety and Efficacy of ABBV-154 in Subjects with Moderately to Severely Active Rheumatoid Arthritis with Inadequate Response to Biologic and/or Targeted Synthetic Disease-Modifying Anti-Rheumatic Drugs (b/tsDMARDs)Moderate to Severe Rheumatoid ArthritisMedDRA version: 23.1Level: PTClassification code 10039073Term: Rheumatoid arthritisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2020-005303-39-GRAbbVie Deutschland GmbH & Co. KG425
Active, not recruiting
Not Applicable
A study to evaluate the effect and safety of a 4 week treatment plan of Alirocumab in patients with high cholesterolPrimary HypercholesterolemiaMedDRA version: 16.1Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861Therapeutic area: Diseases [C] - Nutritional and Metabolic Diseases [C18]EUCTR2013-002343-29-SKRegeneron Pharmaceuticals, Inc.803